Abstract

Background

Immersive virtual reality (VR) is an innovative strategy for inpatient rehabilitation programs. Using immersive VR in early mobilization protocols has not yet been investigated in the setting of hospitalized patients with acute decompensated heart failure (ADHF), especially to improve perceived dyspnea, a common symptom of heart failure (HF).

Methods

This is a single-center parallel superiority randomized clinical trial. The study will be conducted at a public teaching hospital in Brazil from January 2023 to January 2024. The sample will include adult patients with ADHF hospitalized for at least 24 h, randomly assigned in a 1:1 ratio to the control (standard early mobilization protocol conducted in the intensive care unit (ICU)) or intervention group (the same standard early mobilization protocol but associated with immersive VR). The primary outcome will be assessing perceived dyspnea, and the secondary outcome will be assessing patient experience.

Discussion

Using immersive VR in early mobilization protocols in the ICU is expected to improve perceived dyspnea in patients with ADHF as well as patient experience regarding care. This study has the potential to increase patient adherence to early mobilization protocols in the setting of ADHF as well as to promote a positive patient experience. Filling this gap could promote the rational incorporation of technologies in health care.

Trial registration

This study protocol is in its first version. ClinicalTrials.gov NCT05596292. Registered on 1 December 2022.

Details

Title
Perceived dyspnea and experience of hospitalized patients with acute decompensated heart failure undergoing an early MObilization protocol with immersive Virtual rEality: MOVE study protocol for a parallel superiority randomized clinical trial
Author
Fraga, Iasmin Borges 1 ; Caballero, Larissa Gussatschenko 2 ; Lago, Pedro Dal 3 ; de Oliveira, João Lucas Campos 4 ; Scherer, Marina 5 ; Haeffner, Mauren Porto 5 ; Rabelo-Silva, Eneida Rejane 6   VIAFID ORCID Logo 

1  Universidade Federal Do Rio Grande Do Sul, Graduate Program in Cardiology and Cardiovascular Sciences, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498) 
2  Universidade Federal Do Rio Grande Do Sul, Graduate Program Program of the School of Nursing, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498); Hospital de Clínicas de Porto Alegre, Cardiology Division and Heart Failure Clinic, Porto Alegre, Brazil (GRID:grid.414449.8) (ISNI:0000 0001 0125 3761) 
3  Universidade Federal de Ciências da Saúde de Porto Alegre, Graduate Program in Rehabilitation Sciences, Porto Alegre, Brazil (GRID:grid.412344.4) (ISNI:0000 0004 0444 6202) 
4  Universidade Federal Do Rio Grande Do Sul, Graduate Program Program of the School of Nursing, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498) 
5  Hospital de Clínicas de Porto Alegre, Cardiology Division and Heart Failure Clinic, Porto Alegre, Brazil (GRID:grid.414449.8) (ISNI:0000 0001 0125 3761) 
6  Universidade Federal Do Rio Grande Do Sul, Graduate Program in Cardiology and Cardiovascular Sciences, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498); Universidade Federal Do Rio Grande Do Sul, Graduate Program Program of the School of Nursing, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498); Hospital de Clínicas de Porto Alegre, Cardiology Division and Heart Failure Clinic, Porto Alegre, Brazil (GRID:grid.414449.8) (ISNI:0000 0001 0125 3761) 
Pages
751
Publication year
2023
Publication date
Dec 2023
Publisher
Springer Nature B.V.
e-ISSN
17456215
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s13063-023-07786-z
ProQuest document ID
2893280501
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.